Test a drug idea to activate fat that burns energy
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 2 study tests whether a medication approach can activate “beige” fat, which may help the body burn more energy. It mainly looks for people with higher body weight and prediabetes who are not on diabetes medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is between 27 and 45
- You have prediabetes, such as A1c 5.7 to 6.4
- Your prediabetes is due to impaired fasting glucose or impaired glucose tolerance
- You do not have diabetes
- You are not taking diabetes medications regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether mirabegron and tadalafil can improve blood sugar control in people with prediabetes. It may help determine if these medicines can slow the move from prediabetes toward diabetes.
This Phase 2 study tests whether a combination medicine—alpha-lipoic acid plus mirabegron—can help people manage obesity. It will study safety and whether the treatment can improve weight-related outcomes in adults.
This Phase 1 study tests how chronic treatment with a beta-3–type medicine affects brown fat (a special kind of body fat) in the body. It mainly looks at safety and how the body responds over time, which could help future treatments for weight and metabolic health.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.